Testis cancer: the UK as a model

Over the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatme...

Full description

Saved in:
Bibliographic Details
Published in:Urologe. Ausgabe A 2009-04, Vol.48 (4), p.386
Main Authors: Maddineni, S B, Clarke, N W
Format: Article
Language:ger
Subjects:
Humans
Male
Medical Oncology - trends
Testicular Neoplasms - diagnosis
Testicular Neoplasms - therapy
United Kingdom
Urology - trends
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page 386
container_title Urologe. Ausgabe A
container_volume 48
creator Maddineni, S B
Clarke, N W
description Over the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatment options for urological cancers has proven to be an effective approach to managing testis cancer by drawing on interdisciplinary expertise and applying insights gained from ongoing R&D. This strategy could become a model for treating other cancers as well.
doi_str_mv 10.1007/s00120-009-1949-9
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_19352606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19352606</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-6a12dcef62d91165f79baceb3b5b77175788e5543d235b0aa9286aac07435f883</originalsourceid><addsrcrecordid>eNo1zrtOAkEUgOEJiREEH4DGzAuMnjNn52ZniKKRhAZqcuayAcLqZmctfHsLtfq7L78QS4R7BHAPFQA1KICgMDRBhYmYYUOkwFiaiptazwBgg9PXYoqBjLZgZ0LuSh1PVSb-SGV4lOOxyP275CpZdp-5XBbiquVLLbd_nYv9y_Nu9ao22_Xb6mmjegQ_Ksuocyqt1TkgWtO6EDmVSNFE59AZ530xpqGsyURgDtpb5gSuIdN6T3Nx9-v2X7Er-dAPp46H78P_Kv0AuOM8Fw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Testis cancer: the UK as a model</title><source>Alma/SFX Local Collection</source><creator>Maddineni, S B ; Clarke, N W</creator><creatorcontrib>Maddineni, S B ; Clarke, N W</creatorcontrib><description>Over the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatment options for urological cancers has proven to be an effective approach to managing testis cancer by drawing on interdisciplinary expertise and applying insights gained from ongoing R&amp;D. This strategy could become a model for treating other cancers as well.</description><identifier>EISSN: 1433-0563</identifier><identifier>DOI: 10.1007/s00120-009-1949-9</identifier><identifier>PMID: 19352606</identifier><language>ger</language><publisher>Germany</publisher><subject>Humans ; Male ; Medical Oncology - trends ; Testicular Neoplasms - diagnosis ; Testicular Neoplasms - therapy ; United Kingdom ; Urology - trends</subject><ispartof>Urologe. Ausgabe A, 2009-04, Vol.48 (4), p.386</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19352606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maddineni, S B</creatorcontrib><creatorcontrib>Clarke, N W</creatorcontrib><title>Testis cancer: the UK as a model</title><title>Urologe. Ausgabe A</title><addtitle>Urologe A</addtitle><description>Over the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatment options for urological cancers has proven to be an effective approach to managing testis cancer by drawing on interdisciplinary expertise and applying insights gained from ongoing R&amp;D. This strategy could become a model for treating other cancers as well.</description><subject>Humans</subject><subject>Male</subject><subject>Medical Oncology - trends</subject><subject>Testicular Neoplasms - diagnosis</subject><subject>Testicular Neoplasms - therapy</subject><subject>United Kingdom</subject><subject>Urology - trends</subject><issn>1433-0563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNo1zrtOAkEUgOEJiREEH4DGzAuMnjNn52ZniKKRhAZqcuayAcLqZmctfHsLtfq7L78QS4R7BHAPFQA1KICgMDRBhYmYYUOkwFiaiptazwBgg9PXYoqBjLZgZ0LuSh1PVSb-SGV4lOOxyP275CpZdp-5XBbiquVLLbd_nYv9y_Nu9ao22_Xb6mmjegQ_Ksuocyqt1TkgWtO6EDmVSNFE59AZ530xpqGsyURgDtpb5gSuIdN6T3Nx9-v2X7Er-dAPp46H78P_Kv0AuOM8Fw</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Maddineni, S B</creator><creator>Clarke, N W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200904</creationdate><title>Testis cancer: the UK as a model</title><author>Maddineni, S B ; Clarke, N W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-6a12dcef62d91165f79baceb3b5b77175788e5543d235b0aa9286aac07435f883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2009</creationdate><topic>Humans</topic><topic>Male</topic><topic>Medical Oncology - trends</topic><topic>Testicular Neoplasms - diagnosis</topic><topic>Testicular Neoplasms - therapy</topic><topic>United Kingdom</topic><topic>Urology - trends</topic><toplevel>online_resources</toplevel><creatorcontrib>Maddineni, S B</creatorcontrib><creatorcontrib>Clarke, N W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Urologe. Ausgabe A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maddineni, S B</au><au>Clarke, N W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Testis cancer: the UK as a model</atitle><jtitle>Urologe. Ausgabe A</jtitle><addtitle>Urologe A</addtitle><date>2009-04</date><risdate>2009</risdate><volume>48</volume><issue>4</issue><spage>386</spage><pages>386-</pages><eissn>1433-0563</eissn><abstract>Over the course of the past 30 years progress in identification of risk factors, improvements in therapy regimens and advances in treatment delivery have all served to render testis cancer a treatable and survivable malignancy. Institution of specialised oncology centres in the UK to address treatment options for urological cancers has proven to be an effective approach to managing testis cancer by drawing on interdisciplinary expertise and applying insights gained from ongoing R&amp;D. This strategy could become a model for treating other cancers as well.</abstract><cop>Germany</cop><pmid>19352606</pmid><doi>10.1007/s00120-009-1949-9</doi></addata></record>
fulltext fulltext
identifier EISSN: 1433-0563
ispartof Urologe. Ausgabe A, 2009-04, Vol.48 (4), p.386
issn 1433-0563
language ger
recordid cdi_pubmed_primary_19352606
source Alma/SFX Local Collection
subjects Humans
Male
Medical Oncology - trends
Testicular Neoplasms - diagnosis
Testicular Neoplasms - therapy
United Kingdom
Urology - trends
title Testis cancer: the UK as a model
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A55%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Testis%20cancer:%20the%20UK%20as%20a%20model&rft.jtitle=Urologe.%20Ausgabe%20A&rft.au=Maddineni,%20S%20B&rft.date=2009-04&rft.volume=48&rft.issue=4&rft.spage=386&rft.pages=386-&rft.eissn=1433-0563&rft_id=info:doi/10.1007/s00120-009-1949-9&rft_dat=%3Cpubmed%3E19352606%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p108t-6a12dcef62d91165f79baceb3b5b77175788e5543d235b0aa9286aac07435f883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19352606&rfr_iscdi=true